NCT06184685 - Safety and Efficacy of Sahasthara ME vs Diclofenac ME for Treating Primary Knee Osteoarthritis | Biotech Hunter

Enrollment

87

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

November 17, 2021

Study Completion Date

December 8, 2021

Conditions

Primary Knee Osteoarthritis

Interventions

DRUG

Sahasthara Microemulsion

All patients were instructed to treat the knee with 2 ml, 3x/day, for 28 days. Each of the patients received the same appearance of drug packaging, which was not revealed until data analysis was completed, or medical emergency conditions would require an unblinding.

DRUG

Diclofenac Microemulsion

All patients were instructed to treat the knee with 2 ml, 3x/day, for 28 days. Each of the patients received the same appearance of drug packaging, which was not revealed until data analysis was completed, or medical emergency conditions would require an unblinding.

Trial Locations (1)

12120

Thammasat University, Klong Luang